322210.KQ Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
09:30
Aug 10
Hwang Yoo-hyun Private Banker Team Lead, NH Investment & Securities 815 Money Talk (815머니톡)
Biotech normalization bounce, Alteogen leads
Biotech stocks that were heavily battered by the sell-off are staging a violent normalization bounce. Alteogen has broken past resistance despite an upcoming rights offering and is leading the sector higher. ABL Bio, Peptron, OliX and LigaChem are following. The bounce may evolve into a new sector leadership if the rotation continues.
322210.KQ 1ST
MED

About 322210.KQ Analyst Coverage

Buzzberg tracks 322210.KQ across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: Hwang Yoo-hyun.